LFG
ITCI

Larson Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Larson Financial Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17
Closed -$2.24K – 3536
2025
Q1 		$2.24K Buy
17
+15
+750% +$1.87K ﹤0.01% 2133
2024
Q4 		$167 Buy
+2
New +$164 ﹤0.01% 2494

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Larson Financial Group's ITCI Position: Q2 2025 in Review

Larson Financial Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 17 shares — an estimated $2.24K sold.

Larson Financial Group first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $2.24K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Larson Financial Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Larson Financial Group sold 17 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.24K.
  • Larson Financial Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
  • Larson Financial Group's Intra-Cellular Therapies Inc. position peaked at $2.24K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.